Trial Review

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12612000724875
Ethics application status
Approved
Date submitted
5/07/2012
Date registered
6/07/2012
Date last updated
11/07/2016
Type of registration
Prospectively registered

Titles & IDs
Public title
Incidence of Middle Ear Barotrauma In Staged Versus Linear Chamber Compression During Hyperbaric Oxygen Therapy: A Double Blind, Randomized Clinical Trial
Scientific title
All New Patient Receiving Hyperbaric Oxygen Therapy Using Staged Or Linear Chamber Compression And The Incidence Of Middle Ear Barotrauma
Secondary ID [1] 280785 0
Nil
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Middle Ear Barotrauma 286845 0
Condition category
Condition code
Ear 287164 287164 0 0
Other ear disorders

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Staged Chamber Compression using the compression protocol as below:

(atm = atmosphere; min = minutes)

i)Compress from 1atm to 1.28atm @ 1.4meters/min for 2 mins, hold pressure for 1min
ii)Compress from 1.28atm to 1.7atm @ 1.4meters/min for 3mins, hold pressure for 1min
iii)Compress from1.7atm to 2.4atm @ 1.4meters/min for 5mins
Total descent time = 12mins
Intervention code [1] 285214 0
Treatment: Other
Comparator / control treatment
Standard Linear Chamber Compression using standard compression protocol as below:

Compression from 1 atm to 2.4atm @ 1.1meters/min
Total descent time = 12mins 43 secs
Control group
Active

Outcomes
Primary outcome [1] 287465 0
Incidence of middle ear barotrauma.

Both tympanic membranes of each participant will be photographed pre and post hyperbaric treatment with a Welch Allyn Digital Macroview Otoscope by trained staff members using standard mode (no magnification) and auto white balance producing pictures with a resolution of 1280x1024 megapixel in jpeg format.

One set photograph of each ear with a complete view of the tympanic membrane will be taken immediately prior to entering the hyperbaric chamber. Another set of photographs (left and right ears) will be taken within 10mins of the participant exiting the hyperbaric chamber. Each photograph will be assigned a random number.

Any ear wax impeding the view will be removed during the pre treatment assessment i.e. before any photograph is taken.

Middle ear barotrauma is defined as an increase in tympanic membrane (TM) score in one or both ears by at least one grade. The TM score used is based on the modified Teed's score. Photographs of all TMs will be assessed and graded by one single experienced and blinded Otolaryngologist not involved in the clinical care of the participants.
Timepoint [1] 287465 0
Immediately after first hyperbaric oxygen therapy session.
Secondary outcome [1] 298217 0
Number of interrupted treatments. An interrupted treatment is defined as a pause in the compression protocol due to a participant experiencing ear pain / discomfort but successfully arriving at prescribed depth (2.4atm).

Any interrupted treatment will be recorded and the number of interrupted treatments of both arms compared.
Timepoint [1] 298217 0
During the first hyperbaric oxygen therapy session
Secondary outcome [2] 298227 0
Number of aborted treatments. An aborted treatment is defined as a treatment terminated before reaching the prescribed depth (2.4atm) due to the inability of the participant to equalize the ears despite repeated attempts. The protocol for the inability to equalize ears follow that of the Hyperbaric Medicine Unit, Townsville Hospital, Emergency Protocol 18 (EP18)

Any aborted treatment will be recorded and the number of aborted treatments of both arms compared.
Timepoint [2] 298227 0
During the first hyperbaric oxygen therapy session
Secondary outcome [3] 298228 0
Pain score. A subjective pain score rated directly after reaching the prescribed depth will be recorded by each participant on a numerical rating scale with supporting adjectives at both extreme ends.

Median pain scores of both arms will be compared.
Timepoint [3] 298228 0
During the first hyperbaric oxygen therapy session

Eligibility
Key inclusion criteria
All adults aged 18 or above with indication for hyperbaric oxygen therapy
Minimum age
18 Years
Maximum age
99 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Previous hyperbaric oxygen therapy, contraindications for hyperbaric oxygen therapy, patient with grommets, active otological conditions, tympanic membrane rupture, unconscious patient, prescribed hyperbaric treatment table other than 2.4ATA

Study design
Purpose of the study
Prevention
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
The allocation sequence will be concealed from the hyperbaric doctors enrolling and assessing participants in sequentially numbered, opaque, sealed and stapled envelopes. Corresponding envelopes will be opened only after the enrolled participant is inside the hyperbaric chamber and the chamber door closed.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
A balanced, blocked randomisation procedure will be employed by generating the allocation list based on a random seed using a statistical package and produced by an investigator with no clinical involvement in the trial .

From the allocation list, sequentially numbered, opaque, sealed and stapled envelopes containing the random allocation for the single participants will be produced.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
15/07/2012
Actual
13/09/2012
Date of last participant enrolment
Anticipated
31/12/2013
Actual
8/12/2014
Date of last data collection
Anticipated
31/12/2013
Actual
8/12/2014
Sample size
Target
100
Accrual to date
Final
100
Recruitment in Australia
Recruitment state(s)
QLD

Funding & Sponsors
Funding source category [1] 285580 0
Hospital
Name [1] 285580 0
The Townsville Hospital
Country [1] 285580 0
Australia
Primary sponsor type
Hospital
Name
Queensland Health
Address
The Townsville Hospital, 100 Angus Smith Drive, Douglas, 4814 Queensland
Country
Australia
Secondary sponsor category [1] 284416 0
None
Name [1] 284416 0
Address [1] 284416 0
Country [1] 284416 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 287589 0
Townsville Health Service District Human Research Ethics Committee
Ethics committee address [1] 287589 0
Ethics committee country [1] 287589 0
Australia
Date submitted for ethics approval [1] 287589 0
Approval date [1] 287589 0
28/08/2012
Ethics approval number [1] 287589 0
HREC/12/QTHS/78

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 34398 0
Dr Andrew Wei Aun Ng
Address 34398 0
Hyperbaric Medicine Unit, The Townsville Hospital, 100 Angus Smith Drive, Douglas 4814 QLD
Country 34398 0
Australia
Phone 34398 0
+61744332080
Fax 34398 0
Email 34398 0
[email protected]
Contact person for public queries
Name 17645 0
Dr Andrew Ng
Address 17645 0
Hyperbaric Medicine Unit, The Townsville Hospital, 100 Angus Smith Drive, Douglas 4814 QLD
Country 17645 0
Australia
Phone 17645 0
+61744332080
Fax 17645 0
Email 17645 0
[email protected]
Contact person for scientific queries
Name 8573 0
Dr Andrew Ng
Address 8573 0
Hyperbaric Medicine Unit, The Townsville Hospital, 100 Angus Smith Drive, Douglas 4814 QLD
Country 8573 0
Australia
Phone 8573 0
+61744332080
Fax 8573 0
Email 8573 0
[email protected]

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.